Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Stress of Strains: Inbred Mice in Liver Research.

Rogers AB.

Gene Expr. 2018 Dec 14;19(1):61-67. doi: 10.3727/105221618X15337408678723. Epub 2018 Aug 9.

2.

Antibiotic-induced acceleration of type 1 diabetes alters maturation of innate intestinal immunity.

Zhang XS, Li J, Krautkramer KA, Badri M, Battaglia T, Borbet TC, Koh H, Ng S, Sibley RA, Li Y, Pathmasiri W, Jindal S, Shields-Cutler RR, Hillmann B, Al-Ghalith GA, Ruiz VE, Livanos A, van 't Wout AB, Nagalingam N, Rogers AB, Sumner SJ, Knights D, Denu JM, Li H, Ruggles KV, Bonneau R, Williamson RA, Rauch M, Blaser MJ.

Elife. 2018 Jul 25;7. pii: e37816. doi: 10.7554/eLife.37816.

3.

High Frequency of Ovarian Cyst Development in Vhl2B/+;Snf5+/- Mice.

Kuwahara Y, Kennedy LM, Karnezis AN, Mora-Blanco EL, Rogers AB, Fletcher CD, Huntsman DG, Roberts CWM, Rathmell WK, Weissman BE.

Am J Pathol. 2018 Jul;188(7):1510-1516. doi: 10.1016/j.ajpath.2018.03.010. Epub 2018 Apr 22.

PMID:
29684361
4.

Correction for Jandhyala et al., "Activation of the Classical Mitogen-Activated Protein Kinases Is Part of the Shiga Toxin-Induced Ribotoxic Stress Response and May Contribute to Shiga Toxin-Induced Inflammation".

Jandhyala DM, Ahluwalia A, Schimmel JJ, Rogers AB, Leong JM, Thorpe CM.

Infect Immun. 2017 Dec 19;86(1). pii: e00753-17. doi: 10.1128/IAI.00753-17. Print 2018 Jan. No abstract available.

5.

Intergenerational transfer of antibiotic-perturbed microbiota enhances colitis in susceptible mice.

Schulfer AF, Battaglia T, Alvarez Y, Bijnens L, Ruiz VE, Ho M, Robinson S, Ward T, Cox LM, Rogers AB, Knights D, Sartor RB, Blaser MJ.

Nat Microbiol. 2018 Feb;3(2):234-242. doi: 10.1038/s41564-017-0075-5. Epub 2017 Nov 27.

6.

Identification and characterization of T reg-like cells in zebrafish.

Kasheta M, Painter CA, Moore FE, Lobbardi R, Bryll A, Freiman E, Stachura D, Rogers AB, Houvras Y, Langenau DM, Ceol CJ.

J Exp Med. 2017 Dec 4;214(12):3519-3530. doi: 10.1084/jem.20162084. Epub 2017 Oct 24.

7.

Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice.

Livanos AE, Greiner TU, Vangay P, Pathmasiri W, Stewart D, McRitchie S, Li H, Chung J, Sohn J, Kim S, Gao Z, Barber C, Kim J, Ng S, Rogers AB, Sumner S, Zhang XS, Cadwell K, Knights D, Alekseyenko A, Bäckhed F, Blaser MJ.

Nat Microbiol. 2016 Aug 22;1(11):16140. doi: 10.1038/nmicrobiol.2016.140.

8.

Native and bone marrow-derived cell mosaicism in gastric carcinoma in H. pylori-infected p27-deficient mice.

Zhang S, Kim W, Pham TT, Rogers AB, Houghton JM, Moss SF.

Oncotarget. 2016 Oct 25;7(43):69136-69148. doi: 10.18632/oncotarget.12049.

9.

Activation of the Classical Mitogen-Activated Protein Kinases Is Part of the Shiga Toxin-Induced Ribotoxic Stress Response and May Contribute to Shiga Toxin-Induced Inflammation.

Jandhyala DM, Ahluwalia A, Schimmel JJ, Rogers AB, Leong JM, Thorpe CM.

Infect Immun. 2015 Oct 19;84(1):138-48. doi: 10.1128/IAI.00977-15. Print 2016 Jan. Erratum in: Infect Immun. 2017 Dec 19;86(1):.

10.

Inflammasome-independent role of AIM2 in suppressing colon tumorigenesis via DNA-PK and Akt.

Wilson JE, Petrucelli AS, Chen L, Koblansky AA, Truax AD, Oyama Y, Rogers AB, Brickey WJ, Wang Y, Schneider M, Mühlbauer M, Chou WC, Barker BR, Jobin C, Allbritton NL, Ramsden DA, Davis BK, Ting JP.

Nat Med. 2015 Aug;21(8):906-13. doi: 10.1038/nm.3908. Epub 2015 Jun 24.

11.

Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model.

Zhang S, Lee DS, Morrissey R, Aponte-Pieras JR, Rogers AB, Moss SF.

Cancer Lett. 2015 Apr 10;359(2):345-51. Erratum in: Cancer Lett. 2015 Apr 10;359(2):344.

PMID:
25853150
12.

Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss.

Sendor AB, Hacker KE, Chen S, Corona AL, Sen O, Chiang DY, Snavely A, Rogers AB, Montgomery SA, Rathmell WK, McRee AJ.

Gastrointest Cancer. 2015 Feb 1;5:61-71.

13.

Role of Raf kinase inhibitor protein in Helicobacter pylori-mediated signaling in gastric cancer.

Nisimova L, Wen S, Cross-Knorr S, Rogers AB, Moss SF, Chatterjee D.

Crit Rev Oncog. 2014;19(6):469-81. Review.

14.

Effects of tumor microenvironment heterogeneity on nanoparticle disposition and efficacy in breast cancer tumor models.

Song G, Darr DB, Santos CM, Ross M, Valdivia A, Jordan JL, Midkiff BR, Cohen S, Nikolaishvili-Feinberg N, Miller CR, Tarrant TK, Rogers AB, Dudley AC, Perou CM, Zamboni WC.

Clin Cancer Res. 2014 Dec 1;20(23):6083-95. doi: 10.1158/1078-0432.CCR-14-0493. Epub 2014 Sep 17.

15.

Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model.

Zhang S, Lee DS, Morrissey R, Aponte-Pieras JR, Rogers AB, Moss SF.

Cancer Lett. 2014 Dec 1;355(1):106-12. doi: 10.1016/j.canlet.2014.09.010. Epub 2014 Sep 11.

16.

Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences.

Cox LM, Yamanishi S, Sohn J, Alekseyenko AV, Leung JM, Cho I, Kim SG, Li H, Gao Z, Mahana D, Zárate Rodriguez JG, Rogers AB, Robine N, Loke P, Blaser MJ.

Cell. 2014 Aug 14;158(4):705-721. doi: 10.1016/j.cell.2014.05.052.

17.

Prolactin prevents hepatocellular carcinoma by restricting innate immune activation of c-Myc in mice.

Hartwell HJ, Petrosky KY, Fox JG, Horseman ND, Rogers AB.

Proc Natl Acad Sci U S A. 2014 Aug 5;111(31):11455-60. doi: 10.1073/pnas.1404267111. Epub 2014 Jul 21.

18.

Cardio-metabolic effectsof HIV protease inhibitors (lopinavir/ritonavir).

Reyskens KM, Fisher TL, Schisler JC, O'Connor WG, Rogers AB, Willis MS, Planesse C, Boyer F, Rondeau P, Bourdon E, Essop MF.

PLoS One. 2013 Sep 30;8(9):e73347. doi: 10.1371/journal.pone.0073347. eCollection 2013. Erratum in: PLoS One. 2013;8(11). doi:10.1371/annotation/a1e2a42f-7f10-4654-a042-57d19de50208.

19.

Codelivery of VEGF siRNA and gemcitabine monophosphate in a single nanoparticle formulation for effective treatment of NSCLC.

Zhang Y, Schwerbrock NM, Rogers AB, Kim WY, Huang L.

Mol Ther. 2013 Aug;21(8):1559-69. doi: 10.1038/mt.2013.120. Epub 2013 Jun 18.

20.

CCR2 and CD44 promote inflammatory cell recruitment during fatty liver formation in a lithogenic diet fed mouse model.

Egan CE, Daugherity EK, Rogers AB, Abi Abdallah DS, Denkers EY, Maurer KJ.

PLoS One. 2013 Jun 7;8(6):e65247. doi: 10.1371/journal.pone.0065247. Print 2013.

21.

Delivering a behavior-change weight management program to teachers and state employees in North Carolina.

Dunn C, Whetstone LM, Kolasa KM, Jayaratne KS, Thomas C, Aggarwal S, Herget C, Rogers AB.

Am J Health Promot. 2013 Jul-Aug;27(6):378-83. doi: 10.4278/ajhp.120221-QUAN-101. Epub 2013 Mar 7.

PMID:
23470189
22.

Establishment and characterization of MRT cell lines from genetically engineered mouse models and the influence of genetic background on their development.

Kuwahara Y, Mora-Blanco EL, Banine F, Rogers AB, Fletcher C, Sherman LS, Roberts CW, Weissman BE.

Int J Cancer. 2013 Jun 15;132(12):2767-77. doi: 10.1002/ijc.27976. Epub 2012 Dec 27.

23.

Shiga toxin 2-induced intestinal pathology in infant rabbits is A-subunit dependent and responsive to the tyrosine kinase and potential ZAK inhibitor imatinib.

Stone SM, Thorpe CM, Ahluwalia A, Rogers AB, Obata F, Vozenilek A, Kolling GL, Kane AV, Magun BE, Jandhyala DM.

Front Cell Infect Microbiol. 2012 Nov 8;2:135. doi: 10.3389/fcimb.2012.00135. eCollection 2012.

24.

Histologic scoring of gastritis and gastric cancer in mouse models.

Rogers AB.

Methods Mol Biol. 2012;921:189-203. Review.

PMID:
23015505
25.
26.

Intestinal inflammation targets cancer-inducing activity of the microbiota.

Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan TJ, Campbell BJ, Abujamel T, Dogan B, Rogers AB, Rhodes JM, Stintzi A, Simpson KW, Hansen JJ, Keku TO, Fodor AA, Jobin C.

Science. 2012 Oct 5;338(6103):120-3. doi: 10.1126/science.1224820. Epub 2012 Aug 16.

27.

The DNA damage checkpoint protein ATM promotes hepatocellular apoptosis and fibrosis in a mouse model of non-alcoholic fatty liver disease.

Daugherity EK, Balmus G, Al Saei A, Moore ES, Abi Abdallah D, Rogers AB, Weiss RS, Maurer KJ.

Cell Cycle. 2012 May 15;11(10):1918-28. doi: 10.4161/cc.20259. Epub 2012 May 15.

28.

NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling.

Allen IC, Wilson JE, Schneider M, Lich JD, Roberts RA, Arthur JC, Woodford RM, Davis BK, Uronis JM, Herfarth HH, Jobin C, Rogers AB, Ting JP.

Immunity. 2012 May 25;36(5):742-54. doi: 10.1016/j.immuni.2012.03.012. Epub 2012 Apr 12.

29.

Insulin resistance and metabolic hepatocarcinogenesis with parent-of-origin effects in A×B mice.

Hines IN, Hartwell HJ, Feng Y, Theve EJ, Hall GA, Hashway S, Connolly J, Fecteau M, Fox JG, Rogers AB.

Am J Pathol. 2011 Dec;179(6):2855-65. doi: 10.1016/j.ajpath.2011.08.014. Epub 2011 Oct 1.

30.

17 β-estradiol suppresses Helicobacter pylori-induced gastric pathology in male hypergastrinemic INS-GAS mice.

Ohtani M, Ge Z, García A, Rogers AB, Muthupalani S, Taylor NS, Xu S, Watanabe K, Feng Y, Marini RP, Whary MT, Wang TC, Fox JG.

Carcinogenesis. 2011 Aug;32(8):1244-50. doi: 10.1093/carcin/bgr072. Epub 2011 May 11.

31.

Expression of p16(INK4a) prevents cancer and promotes aging in lymphocytes.

Liu Y, Johnson SM, Fedoriw Y, Rogers AB, Yuan H, Krishnamurthy J, Sharpless NE.

Blood. 2011 Mar 24;117(12):3257-67. doi: 10.1182/blood-2010-09-304402. Epub 2011 Jan 18.

32.

HelicoVax: epitope-based therapeutic Helicobacter pylori vaccination in a mouse model.

Moss SF, Moise L, Lee DS, Kim W, Zhang S, Lee J, Rogers AB, Martin W, De Groot AS.

Vaccine. 2011 Mar 3;29(11):2085-91. doi: 10.1016/j.vaccine.2010.12.130. Epub 2011 Jan 12.

33.

K-ras mutation targeted to gastric tissue progenitor cells results in chronic inflammation, an altered microenvironment, and progression to intraepithelial neoplasia.

Okumura T, Ericksen RE, Takaishi S, Wang SS, Dubeykovskiy Z, Shibata W, Betz KS, Muthupalani S, Rogers AB, Fox JG, Rustgi AK, Wang TC.

Cancer Res. 2010 Nov 1;70(21):8435-45. doi: 10.1158/0008-5472.CAN-10-1506. Epub 2010 Oct 19.

34.

Experimental Helicobacter marmotae infection in A/J mice causes enterohepatic disease.

Patterson MM, Rogers AB, Fox JG.

J Med Microbiol. 2010 Oct;59(Pt 10):1235-41. doi: 10.1099/jmm.0.020479-0. Epub 2010 Jul 8.

35.

The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer.

Allen IC, TeKippe EM, Woodford RM, Uronis JM, Holl EK, Rogers AB, Herfarth HH, Jobin C, Ting JP.

J Exp Med. 2010 May 10;207(5):1045-56. doi: 10.1084/jem.20100050. Epub 2010 Apr 12.

36.

The state health plan's commitment to prevention: four key strategies to improve member health and strengthen the plan.

Walker JW, Rogers AB, Morton S.

N C Med J. 2010 Jan-Feb;71(1):65-8. No abstract available.

PMID:
20369678
37.

Distance burning: how gut microbes promote extraintestinal cancers.

Rogers AB.

Gut Microbes. 2011 Jan-Feb;2(1):52-7. doi: 10.4161/gmic.2.1.14761.

38.

Conditional deletion of IkappaB-kinase-beta accelerates helicobacter-dependent gastric apoptosis, proliferation, and preneoplasia.

Shibata W, Takaishi S, Muthupalani S, Pritchard DM, Whary MT, Rogers AB, Fox JG, Betz KS, Kaestner KH, Karin M, Wang TC.

Gastroenterology. 2010 Mar;138(3):1022-34.e1-10. doi: 10.1053/j.gastro.2009.11.054. Epub 2009 Dec 4.

39.

Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens.

Fox JG, Feng Y, Theve EJ, Raczynski AR, Fiala JL, Doernte AL, Williams M, McFaline JL, Essigmann JM, Schauer DB, Tannenbaum SR, Dedon PC, Weinman SA, Lemon SM, Fry RC, Rogers AB.

Gut. 2010 Jan;59(1):88-97. doi: 10.1136/gut.2009.183749.

40.

Combination of sulindac and antimicrobial eradication of Helicobacter pylori prevents progression of gastric cancer in hypergastrinemic INS-GAS mice.

Lee CW, Rickman B, Rogers AB, Muthupalani S, Takaishi S, Yang P, Wang TC, Fox JG.

Cancer Res. 2009 Oct 15;69(20):8166-74. doi: 10.1158/0008-5472.CAN-08-3856. Epub 2009 Oct 13.

41.

Fibroblastic colony-forming unit bone marrow cells delay progression to gastric dysplasia in a helicobacter model of gastric tumorigenesis.

Wang SS, Asfaha S, Okumura T, Betz KS, Muthupalani S, Rogers AB, Tu S, Takaishi S, Jin G, Yang X, Wu DC, Fox JG, Wang TC.

Stem Cells. 2009 Sep;27(9):2301-11. doi: 10.1002/stem.165.

42.

Gastrin is an essential cofactor for helicobacter-associated gastric corpus carcinogenesis in C57BL/6 mice.

Takaishi S, Tu S, Dubeykovskaya ZA, Whary MT, Muthupalani S, Rickman BH, Rogers AB, Lertkowit N, Varro A, Fox JG, Wang TC.

Am J Pathol. 2009 Jul;175(1):365-75. doi: 10.2353/ajpath.2009.081165.

43.

Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver.

Longato L, de la Monte S, Kuzushita N, Horimoto M, Rogers AB, Slagle BL, Wands JR.

Hepatology. 2009 Jun;49(6):1935-43. doi: 10.1002/hep.22856.

44.

Helicobacter-based mouse models of digestive system carcinogenesis.

Rogers AB, Houghton J.

Methods Mol Biol. 2009;511:267-95. doi: 10.1007/978-1-59745-447-6_11.

PMID:
19347301
45.

Cytolethal distending toxin promotes Helicobacter cinaedi-associated typhlocolitis in interleukin-10-deficient mice.

Shen Z, Feng Y, Rogers AB, Rickman B, Whary MT, Xu S, Clapp KM, Boutin SR, Fox JG.

Infect Immun. 2009 Jun;77(6):2508-16. doi: 10.1128/IAI.00166-09. Epub 2009 Mar 23.

46.

Concurrent Helicobacter bilis infection in C57BL/6 mice attenuates proinflammatory H. pylori-induced gastric pathology.

Lemke LB, Ge Z, Whary MT, Feng Y, Rogers AB, Muthupalani S, Fox JG.

Infect Immun. 2009 May;77(5):2147-58. doi: 10.1128/IAI.01395-08. Epub 2009 Feb 17.

47.

Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice.

Erdman SE, Rao VP, Poutahidis T, Rogers AB, Taylor CL, Jackson EA, Ge Z, Lee CW, Schauer DB, Wogan GN, Tannenbaum SR, Fox JG.

Proc Natl Acad Sci U S A. 2009 Jan 27;106(4):1027-32. doi: 10.1073/pnas.0812347106. Epub 2009 Jan 21.

48.

Acute respiratory distress syndrome in two rhesus macaques (Macaca mulatta).

Fremont JJ, Marini RP, Fox JG, Rogers AB.

J Am Assoc Lab Anim Sci. 2008 Sep;47(5):61-6.

49.

Recommendation for and receipt of cancer screenings among medicaid recipients 50 years and older.

DuBard CA, Schmid D, Yow A, Rogers AB, Lawrence WW.

Arch Intern Med. 2008 Oct 13;168(18):2014-21. doi: 10.1001/archinte.168.18.2014.

PMID:
18852404
50.

Cytotoxic-T-lymphocyte-associated antigen 4 blockade abrogates protection by regulatory T cells in a mouse model of microbially induced innate immune-driven colitis.

Watanabe K, Rao VP, Poutahidis T, Rickman BH, Ohtani M, Xu S, Rogers AB, Ge Z, Horwitz BH, Fujioka T, Erdman SE, Fox JG.

Infect Immun. 2008 Dec;76(12):5834-42. doi: 10.1128/IAI.00542-08. Epub 2008 Sep 29.

Supplemental Content

Loading ...
Support Center